【摘 要】
：
Targeting ligands are anticipated to facilitate precise delivery of therapeutic agents to diseased tissues by recognizing the overexpressed corresponding receptors; however,they may also severely affe
【机 构】
：
School of Basic Medical Sciences & State Key Laboratory of Molecular Engineering of Polymers,Fudan U
【出 处】
：
第三届国际纳米药物大会 ChinaNanomedicine 2018 The 3rd International Con
论文部分内容阅读
Targeting ligands are anticipated to facilitate precise delivery of therapeutic agents to diseased tissues by recognizing the overexpressed corresponding receptors; however,they may also severely affect the interaction of nanocarriers with plasma proteins,determining what is “seen” by living organisms.
其他文献
Purpose:Physical dose distribution in radiotherapy treatment plans may not represent a useful clinical tool due to the variation of biological effect of dose fractionation of various tissues.We aimed
Herein,we reported a shape-changeable micelle composed of two kinds of triblock copolymers,BR-FFVLK-PEG and Ce6-FFVLK-PEG,which both included(i)functional hydrophobic block(bilirubin,BR or chlorin e6,
Herein,poly(L-lactic acid)(PLLA)nanofibrous spongy microspheres(NFSMS),PLLA/polyethylene glycol(PEG)co-functionalized mesoporous silica nanoparticles(MSN),and poly(lactic acid-co-glycolic acid)microsp
Generation of tumor-specific T cells is critically important for cancer immunotherapy.A major challenge in achieving a robust adaptive T cell response is the spatio-temporal orchestration of antigen c
Our previous work demonstrated that Wnt16 expression in cisplatin-damaged tumor-associated fibroblasts is a key factor contributing to cisplatin resistance in malignancies.Natural antifibrotic compoun
With the recent advances of cancer immunotherapy,cancer vaccines have regained the attention of academia and the pharmaceutical industry for their potential synergy with existing therapies [1,2].
More and more researches have revealed that chemotherapy drugs not only induce tumor cell apoptosis but also activate autophagy.Ambroxol(Ax)as a molecular chaperone could activate coordinated lysosoma
The outcome of molecular targeted therapies is restricted by the ambiguous molecular subtypes of non-small cell lung cancer(NSCLC)which are difficult to be defined with druggable mutations,and the ine
Cancer immunotherapies by training or stimulating the inherent immunological systems to recognize,attack,and eradicate tumour cells with minimal damage to healthy cells have demonstrated promising cli
We developed an anticancer siRNA delivery system(named HLPR)having the functions of CD44 and epidermal growth factor receptor(EGFR)dual-targeting through modular strategy without the chemical covalenc